|
Chemotherapy Related Anemia Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Chemotherapy Related Anemia conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Chemotherapy Related Anemia Clinical research trials and Chemotherapy Related Anemia medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Chemotherapy Related Anemia. Chemotherapy Related Anemia Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Chemotherapy Related Anemia clinical trial. Subjects typically recieve the finest healthcare available for their Chemotherapy Related Anemia condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Chemotherapy Related Anemia Chemotherapy Related Anemia
Chemotherapy Related Anemia
For Condition: Lung Neoplasms,Lymphoma,Breast Neoplasms,Leukemia, Lymphocytic, Chronic,Multiple Myeloma
Status: Completed
Sponsor(s): Amgen ,
Synopsis: This study is investigating darbepoetin alfa for the treatment of anemia in patients with non-myeloid cancers who are receiving chemotherapy. Darbepoetin alfa is a recombinant protein that stimulates the production of red blood cells. In this study, darbepoetin alfa will be administered as either an injection under the skin (subcutaneously) or directly into a vein (intravenously).
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Non-myeloid malignancy (i.e., solid tumors, lymphomas, multiple myeloma, and CLL) - At least 12 weeks of cyclic chemotherapy planned, regardless of schedule - Hemoglobin = 11.0 g/dL
Total Enrollment:
Location and Contact Information:
Research Center
San Diego, California,
United States
Research Center
Jacksonville, Florida,
United States
Research Center
Albuquerque, New Mexico,
United States
Research Center
Lake Worth, Florida,
United States
Research Center
Seattle, Washington,
United States
Research Center
Houston, Texas,
United States
Research Center
Newport News, Virginia,
United States
Research Center
Orange, California,
United States
Research Center
Fountain Valley, California,
United States
Research Center
Salem, Virginia,
United States
Additional Information:
Study ID Numbers: 20010199;
Study Start Date:
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035607
Other Lymphoma Studies:
1. CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
2. Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
3. Phase II Liposomal Vincristine for Pediatric and Adolescent Patients with Relapsed Malignancies
4. Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
5. Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Related Studies:
Other Lymphoma Clinical Trials
Other California Clinical Trials
Other Fountain Valley Clinical Trials
Chemotherapy Related Anemia
|
|
|
|
|
|
|
|